Smith & Nephew’s announced that they received FDA approval for their EXOGEN 4000+ Bone Healing System. Company touts its product as “the ONLY bone stimulator using ultrasound technology approved to treat fractures that that have failed to heal; approved to heal specific fresh fractures faster.”
The EXOGEN Bone Healing System utilizes low-intensity ultrasound to accelerate the healing of indicated fresh fractures up to 38% faster than normal healing. This treatment is often used for returning professional athletes to fitness as quickly as possible. There are economic benefits generally for individuals and organisations with people returning to work after injury more quickly. Faster recovery is in the interests of all patients, clinicians and health care providers.
The EXOGEN Bone Healing System is also highly effective for use on non-healing fractures. These fractures are a significant problem and a major cost to healthcare systems around the world. Clearly patients who suffer fractures which will not heal suffer great frustration and anxiety, and treatment from EXOGEN provides an improved chance to recover, invaluable for patients who may have previously been largely confined to hospital or their homes.
The ultrasound device is a portable, lightweight unit that delivers the prescribed treatment in a convenient 20 minute daily regimen. The ease of use offered means that patients can treat themselves at home, thus freeing hospital resources from this task. The unit’s digital display guides patients step by step through proper operation and the main unit monitors treatment providing the clinician with an accurate record for reference.
The treatment is safe and has no contra-indications. It has been clinically proven in many thousands of patients worldwide.